Madhura Milind Nimonkar
Overview
    Explore the profile of Madhura Milind Nimonkar including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              5
            
            
              Citations
              7
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Nimonkar M, Arunachal G, Kotambail A, Sukrutha R, Raghavendra K, Chetan G, et al.
  
  
    Stem Cell Res
    . 2025 Feb;
          84:103672.
    
    PMID: 39923287
  
  
          We report the iPSC line NIMHi014-A, generated from the PBMCs of an epileptic girl child. The proband harbours a de novo, pathogenic variant of the SCN1A gene, which encodes the...
      
2.
        
    
    Nandeesh B, Maheshwari B, Nimonkar M, Deepha S, Govindaraj P, Mehta B, et al.
  
  
    Stem Cell Res
    . 2025 Jan;
          83:103654.
    
    PMID: 39787833
  
  
          PGK1 (phosphoglycerate kinase-1) is required for ATP production in the body. Mutation in the PGK1 gene causes a rare, inherited metabolic disorder causing deficiency of enzyme PGK1, leading to hemolytic...
      
3.
        
    
    Arunachal G, Nimonkar M, Mahadeva P, Sukrutha R, Raghavendra K, Chetan G, et al.
  
  
    Stem Cell Res
    . 2024 Oct;
          81:103573.
    
    PMID: 39383605
  
  
          The iPSC line NIMHi013-A was generated from peripheral blood mononuclear cells of a paediatric patient with drug resistant epilepsy. The proband was found to have a likely pathogenic missense variant...
      
4.
        
    
    Dash S, Arunachal G, Nimonkar M, Vengalil S, Nashi S, Chetan G, et al.
  
  
    Stem Cell Res
    . 2024 Feb;
          76:103355.
    
    PMID: 38412659
  
  
          In this study, we have established human induced pluripotent stem cell (hiPSC) line, NIMHi010-A of a 42-year-old healthy donor. The iPSC line was generated from human dermal fibroblasts using Sendai...
      
5.
        
    
    Arunachal G, Nimonkar M, Raghavendra K, Chetan G, Mehta B, Markandeya Y
  
  
    Stem Cell Res
    . 2024 Feb;
          76:103349.
    
    PMID: 38368738
  
  
          Human induced pluripotent stem cells provide an exceptional platform for studying pathogenesis in vitro. We, therefore, have generated and characterized human induced pluripotent stem cell (iPSC) line NIMHi009-A derived from...
      
6.
        
    
    Nimonkar M, Arunachal G, Dash S, Kandy S, Raghavendra K, Chetan G, et al.
  
  
    Stem Cell Res
    . 2023 Jun;
          70:103130.
    
    PMID: 37269666
  
  
          We report the generation and characterisation of a human induced pluripotent stem cell (iPSC) line, NIMHi007-A, derived from peripheral blood mononuclear cells (PBMCs) of a healthy female adult individual. PBMCs...
      
7.
        
    
    Kandy S, Nimonkar M, Dash S, Mehta B, Markandeya Y
  
  
    Mar Drugs
    . 2022 Oct;
          20(10).
    
    PMID: 36286468
  
  
          Excitotoxicity is known to associate with neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis and Huntington's disease, as well as aging, stroke, trauma, ischemia and epilepsy. Excessive...